Evaluation of the Usefulness of a PRN Regimen Using Ranibizumab for Macular Edema Due to Branch Retinal Vein Occlusion

NCT02478515 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Branch Retinal Vein Occlusion

Interventions

DRUG: Ranibizumab

Sponsor

Nagoya City University

Collaborators

[object Object]